Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

1 Magnificent Dividend Growth Stock That's Down 40% and Trading at a Once-in-a-Decade Valuation


So far, 2024 has been a year to forget for animal healthcare juggernaut (NYSE: ZTS). Hit by the triple whammy of weak earnings, a formal investigation from the European Commission, and adverse events linked to some of its newest medicines, Zoetis has seen its share price plunge 27% this year and 40% from its all-time highs.

We will get to these issues in a moment, but the silver lining to these recent developments is that Zoetis shares now trade at a once-in-a-decade valuation. So this begs the question: Is Zoetis now a fundamentally flawed business destined to continue dropping? Or is this sell-off a unique opportunity for investors willing to buy and hold for a decade and beyond?

Here's why I'm leaning toward the latter.

Continue reading


Source Fool.com

Zoetis Inc. A Stock

€134.28
-0.060%
With only a change of -€0.080 (-0.060%) the Zoetis Inc. A price is nearly unchanged from yesterday.
Zoetis Inc. A is currently one of the favorites of our community with 18 Buy predictions and no Sell predictions.
With a target price of 192 € there is a positive potential of 42.98% for Zoetis Inc. A compared to the current price of 134.28 €.
Like: 0
ZTS
Share

Comments